| Code |
| PYFA |
| Title |
| PT. Pyridam Farma Tbk |
| Address |
| Head Office | : | | | Address | : | Sinarmas MSIG Tower, Lantai 12, Jl. Jend. Sudirman Kav.21 RT 10/RW1 | | | Kuningan,Karet, Kec. Setiabudi - Jakarta Selatan12920 | | Phone | : | (021) 5369 0112; (021) 5366 0865 - 66 | | Fax | : | (021) 532 9042 | | E-mail | : | corsec@pyfa.co.id | | Website | : | http://pyfa.co.id | | Factory | : | | | | Jl. Hanjawar, Pacet | | | Cianjur 43253 - Jawa Barat | | Phone | : | (0263) 580 844; (0263) 580 855 | | Fax | : | (0263) 580 833 | | E-mail | : | pyridam@universalmail.com | | Website | : | |
|
| Background |
Currently, the Company's activities are engaged in the production and development of pharmaceutical products and trading of medical equipment as well. |
| Business cp product |
Currently, the Company's activities are engaged in the production and development of pharmaceutical products and trading of medical equipment as well. |
| Subsidiary affiliation |
|
| Commissioners |
| President Commissioner | : Robby Yulianto | | | Independent Commissioner | : Mohammad Syamsul Arifin | | | Independent Commissioner | : Maura Linda Sitanggang | | | Independent Commissioner | : Charles D. Marpaung | | | | | | Per 30 Sep 2023 | | |
|
| Directors |
| President Director | : Lee Yan Gwan | | | Independent Director | : dr. (Paulus ) Widjanarko Brotosaputro | | | Independent Director | : Yenfrino Gunadi | | | Independent Director | : Bedjo Stefanus | | | | | | Per 30 Sep 2023 | | |
|
| Underwriter |
| PT. Trimegah Securities Tbk | | PT. Kresna Graha Sekurindo | | | |
| Share registrar |
|
| Share holders |
| Shareholders | Shares | % | | | | Rejuve Global Investment Pte. Ltd | 216582206 | 40.48 | | | | PT Aldiracita Sekuritas Indonesia | 97795906 | 18.27 | | | | DBS Bank Ltd. SG-PB | 41441302 | 7.75 | | | | PT Global Investment Institusi | 29429400 | 5.5 | | | | Public | 149,831186 | 28 | | | | | | | | | As of Nov 08, 2023 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @Rp. 10516-Oct-2001100120000000520000000 Dividen Saham 14.5 : 50021-Nov-200210015080000535080000
|
| Other infos |
|
| Created date |
| 2023-11-17 14:38:48 |
| Revised date |
| 2023-11-17 14:38:48 |
| Finance |
2023,
2022,
2021,
2020,
2019,
2018,
2017,
2016,
2015,
2014,
2013,
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|